Table 3.
Relationships Between HNF-1β Expression and Clinicopathological Features in Epithelial Ovarian Cancers*
| n | HNF-1β expression high group (score 3 to 5) | HNF-1β expression low group (score 0 to 2) | P value | |
|---|---|---|---|---|
| All patients | 83 | 22 (27%) | 61 (73%) | |
| Age | ||||
| <60 | 57 | 15 (26%) | 42 (74%) | |
| ≥60 | 26 | 7 (27%) | 19 (73%) | 0.953 |
| Histology | ||||
| Clear cell | 22 | 21 (95%) | 1 (5%) | |
| Serous | 39 | 0 (0%) | 39 (100%) | |
| Mucinous | 11 | 0 (0%) | 11 (100%) | |
| Endometrioid | 11 | 1 (9%) | 10 (91%) | <0.0001 |
| Histologic differentiation | ||||
| Well | 41 | 11 (27%) | 30 (73%) | |
| Moderate | 27 | 8 (30%) | 19 (70%) | |
| Poor | 15 | 3 (20%) | 12 (80%) | 0.793 |
| FIGO stage | ||||
| I/II | 53 | 18 (34%) | 35 (66%) | |
| III/IV | 30 | 4 (13%) | 26 (87%) | 0.041 |
*Chi-square test.